|
|
|
15.12.25 - 07:03
|
Proton Therapy New Standard of Care for Patients with Oropharyngeal Cancer (GlobeNewswire EN)
|
|
|
Louvain-La-Neuve, Belgium, December 15, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy solutions for the treatment of cancer, is pleased to share today that, on December 11, The Lancet – one of the world's most renowned academic journals – published a landmark study that recommends proton therapy as a new standard of care for patients with oropharyngeal cancer. This study, led by MD Anderson Cancer Center, the world's leading hospital for cancer care, is the first-ever randomized controlled trial (RCT) to provide the highest level of evidence demonstrating the benefits of proton therapy over conventional radiotherapy for this indication....
|
|
|
11.12.25 - 07:03
|
China Gold Irradiation Introduces IBA′s sustainable X-ray irradiation technology to expand its production capacity (GlobeNewswire EN)
|
|
|
Louvain-la-Neuve, Belgium, December 11, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and electron beam and X-ray solutions for industrial advanced irradiation, announced today it has signed a contract with China Gold Irradiation (CGI), the largest high standard irradiation service company in China, to install a Rhodotron® in Jiaxing, Zhejiang Province, as a first step of the transition of China's irradiation processing industry to a new stage of high-quality development....
|
|
|
08.12.25 - 07:03
|
YAS Healthcare signs contract for a Proteus®ONE solution, the first proton therapy system to be installed in Dubai, UAE (GlobeNewswire EN)
|
|
|
Louvain-La-Neuve, Belgium, December 8, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy solutions for the treatment of cancer, announces today it has signed a contract with YAS Healthcare, a subsidiary of DAS Holding, to install a Proteus®ONE1 compact proton therapy solution to be located in Dubai, United Arab Emirates (UAE)....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20.08.25 - 07:03
|
Heidelberg University Hospital expands its particle therapy program with IBA′s Proteus®ONE solution (GlobeNewswire EN)
|
|
|
Louvain-La-Neuve, Belgium, August 20, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy solutions for the treatment of cancer and Heidelberg University Hospital (Universitätsklinikum Heidelberg AöR, UKHD) announce today that they have signed a contract to install a Proteus®ONE1 compact proton therapy solution to be located on the University campus in Heidelberg, Germany. The first payment has been received....
|
|
|
|
|
|
|
|
|
|
|
24.03.25 - 17:57
|
IBA – Share buyback (GlobeNewswire EN)
|
|
|
Louvain-la-Neuve, Belgium, March 24th, 2025 - Ion Beam Applications SA (IBA) announces today the launch of a share buyback program, effective as of March 25th, 2025, in application of article 7:215 of the Belgian Companies and Associations Code....
|
|
|
20.03.25 - 10:01
|
Ion Beam Applications Aktie: Gute Zahlen und ordentlicher Ausblick (Aktiencheck)
|
|
|
Kulmbach (www.aktiencheck.de) - Ion Beam Applications-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von Ion Beam Applications SA (IBA) (ISIN: BE0003766806, WKN: 914998, Ticker-Symbol: IOB, Euronext Brüssel-Symbol: IBAB, NASDAQ OTC-Symbol: IBOCF) unter die Lupe. [mehr]...
|
|
|
|
|
04.03.25 - 11:21
|
IBA and Apollo Hospitals sign a term sheet for one Proteus®ONE system plus a second one in option to be installed in India (GlobeNewswire EN)
|
|
|
Louvain-La-Neuve, Belgium, March 04, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and leading provider of proton therapy solutions for the treatment of cancer, today announces it has signed a term sheet with Apollo Hospitals Enterprise Limited (AHEL) for the supply of one Proteus®ONE1 compact proton therapy solution plus a second one in option. Apollo will therefore expand access to proton therapy in India. The term sheet was signed in the presence of Her Royal Highness Princess Astrid of Belgium....
|
|
|
18.02.25 - 16:48
|
Notice of Capital Markets Day - Save the Date (GlobeNewswire EN)
|
|
|
Louvain-la-Neuve, Belgium, 18 February, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, will host a Capital Markets Day (CMD) for investors and analysts on Monday 7 April 2025 at 2pm CET / 1pm GMT / 8am ET....
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
